Advanced Prostate Cancer Consensus Conference: APCCC 2019
Locally advanced prostate cancer, Biochemical recurrence of prostate cancer after local therapy, Management of primary tumour in the metastatic situation, Systemic treatment castration-sensitive/naive prostate cancer, Management of M0 castration-resistant prostate cancer, Management of M1 castration-resistant prostate cancer, Bone and bone metastases, Molecular characterization: Tissue and blood, Heterogeneity of men with prostate cancer (ethnicity, elderly, organ dysfunction), Side effects of hormonal treatments and their management.
c/o Congrex Switzerland Ltd.
Peter Merian-Strasse 80
Fon: +41 61 686 77 77
Fax: +41 61 686 77 88